November 4, 2022 | By John Raslavsky | Diabetes, Liver | Blog, Clinical research, Fatty Liver Disease, Fibroscan, liver health, NAFLD
November is National Diabetes Month. What better time to discuss one of the lesser-known effects of diabetes, its impact on the liver? Diabetes can result in a range of liver conditions, some of which can be serious. In this blog …
October 31, 2022 | By John Raslavsky | News & Events
With all the heavy lifting our liver does daily, it’s easy to forget its connection to specific areas, such as our nervous system. Our latest blog discusses how liver disease can impact mental health in various ways. The Mind and …
October 14, 2022 | By John Raslavsky | Liver Disease, Liver Health | Blog, Clinical research, Fatty Liver Disease, Liver research
Worldwide, liver cancer is the second most common cause of cancer-related death. Yet, with such prevalence, it remains challenging to treat. As numbers continue to rise, the value of liver research is critical to public health. Learn more about …
September 15, 2022 | By John Raslavsky | Liver Health, News & Events | Blog, Clinical research, Fibroscan, liver health, Liver research, NASH, NASH Complications
Many medical conditions like diabetes can lead to other potential health concerns. Read our blog to learn more about the correlation between diabetes and nonalcoholic steatohepatitis (NASH). The Relationship Between Diabetes and NASH Those living with diabetes are more likely to …
August 31, 2022 | By John Raslavsky | Hepatitis, Hepatitis B | Blog, Hepatic Clinical Trials, Vaccination
Don’t turn your back on vaccinations! With an increase in hepatitis B cases, the need for protection has never been more relevant. Learn more on the significance of vaccines, especially against hepatitis B. The Power of Vaccination Simply stated, vaccines …
August 2, 2022 | By John Raslavsky | Dyslipidemia, Fibroscan | Blog, Cholesterol Management, Clinical research, liver health
Often referred to as high cholesterol, dyslipidemia is the imbalance of lipid or fat found in your bloodstream. While moderate lipid levels in your body are okay, high levels can put you at higher risk for other medical health concerns. …
July 22, 2022 | By John Raslavsky | Clinical Research, Hepatitis | Clinical trials, Hepatitis in Children, Hepatitis Outbreak, Liver disease
The Sudden Wave of Hepatitis Amongst Children A recent upsurge in hepatitis cases involving children has caused alarm nationwide. Let’s dive into why this age group is suddenly experiencing a spike in occurrences. An Origin Story – How Cases of …
July 1, 2022 | By John Raslavsky | Cirrhosis, Clinical Research, NASH | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research
At their very root, non-alcoholic steatohepatitis (NASH) and cirrhosis are two medical conditions that affect the liver. However, this seemingly separate duo shares more in common than you may think. When NASH and cirrhosis get together, your liver is at …
June 8, 2022 | By John Raslavsky | Clinical Research, Hepatitis B | Blog, Clinical trials, liver health, Liver research
Like many other liver diseases, hepatitis B is a “silent epidemic” because most people do not have symptoms for most of the disease progression. It is one of the most common serious liver infections globally and in the state of …
May 31, 2022 | By John Raslavsky | Clinical Research, Jaundice, NASH | bilirubin and liver function, Blog, Clinical trials, Liver research, NASH Complications
Jaundice is a yellowing of the eye sclera (the white part) and skin because there’s too much bilirubin in the blood. There are many causes of jaundice. However, for people living with liver disease, jaundice is a common nonalcoholic steatohepatitis …